跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,853 条关于
“LHNVD-202”
全部
9,853
临床试验
3,108
药物
3,363
机构
10
资讯
3,372
去年
Longhorn Vaccines Advances Universal Flu Vaccine with Broad Cross-Species Protection
去年
REGENXBIO's RGX-202 DMD Gene Therapy Enters Pivotal Phase 3 Trial
去年
Radiopharm Theranostics' RAD 202 Receives Ethics Approval for Phase 1 Trial in HER2-Expressing Solid Tumors
去年
IO-202 Plus Azacitidine Shows Promise in Treating CMML
去年
Mobile App OTX-202 Reduces Suicide Attempts by 58% in High-Risk Psychiatric Patients
7个月前
YolTech's YOLT-202 Gene Editing Therapy Shows Promising Results in Alpha-1 Antitrypsin Deficiency Trial
10个月前
Senti Bio to Present Updated SENTI-202 Clinical Data at ASH 2025, Showcasing Logic Gate Technology in AML Treatment
11个月前
AviadoBio Secures $413M Option Deal for UGX-202 Optogenetics Gene Therapy to Restore Vision in Retinitis Pigmentosa
9个月前
Senti Bio's SENTI-202 CAR-NK Therapy Achieves 50% Response Rate in Relapsed/Refractory AML, Receives FDA RMAT Designation
去年
Senti Bio's SENTI-202 Shows Promise in Early AML Trial
第 1 页,共 338 页
上一页
下一页